RAB9B

Across TCGA pan-cancer cohorts, RAB9B RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated RAB9B data layer compared with 1 for mutation status and 2 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RAB9B RNA is associated with better overall survival. In most high-consensus cancer types, elevated RAB9B expression acts as an unfavorable survival marker, although some lineages such as LUAD and LGG show a favorable association.

LUAD, LGG, and PAAD are the cancer types where RAB9B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.877	0.760	<.001	45	view →
LGG	DFS	Median	All	0.478	0.288	<.001	45	view →
PAAD	DFS	Quartile	All	0.583	0.316	<.001	31	view →
ACC	OS	Median	II,III,IV	0.866	0.650	.006	28	view →
UCEC	OS	Quartile	All	0.606	0.803	.009	24	view →
LUSC	DFS	Quartile	III,IV	0.161	0.503	.003	23	view →
MESO	OS	Median	II,III,IV	0.309	0.483	.012	21	view →
CHOL	OS	Median	II,III,IV	0.907	0.419	.011	19	view →
THYM	OS	Tertile	II,III,IV	0.941	0.612	.004	19	view →
CESC	OS	Tertile	IV	0.732	0.289	.011	18	view →
HNSC	OS	Tertile	II,III,IV	0.606	0.739	.014	16	view →
STAD	OS	Quartile	All	0.534	0.714	.002	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

RAB9B–LUAD (OS)

Open the LUAD breakdown →